Physician profile
Suling Li
NPI 1437798436
$695.08
in general payments reported to CMS, 2019-2025
17 companies · $509 in 2025
The $509 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $186 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $204.57 | 2024-2025 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $67.71 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $55.88 | 2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.17 | 2024-2025 | Jardiance, Synjardy |
| Novo Nordisk INC | $42.52 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Ascendis Pharma Endocrinology INC | $28.41 | 2025 | Yorvipath |
| Radius Health, INC. | $27.77 | 2025 | Tymlos |
| Medtronic, INC. | $25.95 | 2024 | Minimed 780g |
| Bayer Healthcare Pharmaceuticals INC. | $25.81 | 2025 | |
| Corcept Therapeutics | $24.82 | 2025 | Korlym |
| Beta Bionics, INC. | $23.81 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Xeris Pharmaceuticals, INC. | $23.04 | 2025 | Recorlev |
| Sanofi-Aventis U.S. LLC | $21.64 | 2024 | |
| Antares Pharma, INC. | $19.34 | 2024 | Xyosted |
| Alexion Pharmaceuticals, INC. | $18.97 | 2025 | Strensiq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.79 | 2025 | |
| Amphastar Pharmaceuticals, INC. | $17.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suling Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.